EN DE
Watch Decibel Cannabis Company Inc for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Decibel Cannabis Company Inc (DB) fair value: what the stock is really worth

As of Nov 4, 2026: fair value (intrinsic value) of Decibel Cannabis Company Inc stock C$3.01, price C$2.00, upside +50.5%, quality 41 out of 100. Rating: strongly undervalued. Calculated from audited financials with 9 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare CA · ISIN CA2434371001

DC Decibel Cannabis Company Inc logo Some data Nov 2, 2026

Decibel Cannabis Company Inc

DB · V
Cheap, value-trap risk

The stock costs 34% less than our calculation considers fair.

Fair value C$3.01 · Strongly undervalued (34%)
Low debt
Last quarter vs. a year ago: revenue +19%, profit +154%.
Quality 41/100
Mixed Growth (revenue 5y +30.4 %/yr in CAD)
Mixed vs. peers (7/12)
Neutral coverage
Some data
Loss-making · -0.5% net margin (TTM)
Negative free cash flow over the last twelve months
Narrow moat 23/100 · thin data

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

C$5.33 C$0.6000 Fair Value C$3.01 Jul 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 2, 2026.

How to read this chart

60‑month range C$0.6000 – C$5.33 · fair‑value band C$1.58 – C$5.91 · the C$2.00 price screens below the C$3.01 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 2, 2026.

Follow Decibel Cannabis Company in your weekly email

Every Wednesday you see whether Decibel Cannabis Company is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Decibel Cannabis Company Inc., an integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada.

Show moreShow less

It is also involved in the extraction, processing, and manufacturing of cannabis derivative products, including vapes, cannabis infused pre-rolls, pre-rolls, edibles, and other value added products.

The company also engages in the business-to-business cannabis product sales in the provinces of Saskatchewan and Alberta; and e-commerce end-user customers in the province of Saskatchewan. It offers its products under the Qwest, Vox, Blendcraft, and General Admission brands.

Decibel Cannabis Company Inc. is headquartered in Calgary, Canada.

Stock analysis

Decibel Cannabis Company Inc (DB) currently trades at C$2.00, while our model-based Fair Value estimate is C$3.01, implying the stock looks roughly 34% undervalued today.

Show more

Valuation

Bull case: the DCF Models group reads highest at a median of C$3.01 per share, and 4 of the 9 models we run sit above the C$2.00 price.

Bear case: the Growth DCF group reads lowest at C$0.6700, and 5 of the 9 models stay below the price. Data coverage for this calculation is medium.

Scenario range: C$1.58 (bear) to C$5.91 (bull), the price of C$2.00 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 41/100 (below-average quality), in the Healthcare sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Decibel Cannabis Company Inc reported revenue of C$113M in FY2025 versus C$52.5M in FY2021, a compound +21.1%/yr. Reported net income was −C$2.9M in FY2025.

Key figures

Market cap C$71.2M (≈ $50.8M) Micro · P/S ratio 0.56 · EPS (TTM) C$−0.1500 · Net margin −2.6% · Return on equity −1.0% · Return on assets (EBIT) 2.0% · Operating margin 16.0% · Revenue (TTM) C$127M.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 23 out of 100 (low confidence).

What moves the price

The share trades about 8% below its 52-week high and 48% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −27% fair-value upside, at 51%, DB screens cheaper than that median.

Fair Value models

Bear C$1.58 Fair Value C$3.01 Bull C$5.91
Price C$2.00 · Upside +50.5%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF C$1.91 C$3.01 C$6.30 76
Growth DCF C$1.75 C$3.39 C$5.96 75
5Y Revenue Exit C$0.3300 C$0.5200 C$0.8800 71
All 9 models by family
DCF Models
FCF DCF C$1.91 C$3.01 C$6.30 76
5Y Revenue Exit C$0.3300 C$0.5200 C$0.8800 71
5Y EBITDA Exit C$1.58 C$3.04 C$5.91 71
10Y Revenue Exit C$0.8600 C$1.55 C$1.70 68
10Y EBITDA Exit C$1.70 C$4.00 C$7.90 64
Multiples
EV/EBITDA C$1.16 C$1.79 C$2.42 66
Asset-Based
NCAV (Graham) C$0.8000 C$1.08 C$1.61 54
Growth DCF
Growth DCF C$1.75 C$3.39 C$5.96 75
Rev-Margin DCF C$0.3800 C$0.6700 C$1.29 69

Open the full fair value analysis →

Quality Score breakdown

Overall quality 41/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 25
How much profit the company makes from its sales and capital
Quality Growth 40
Are margins and returns getting better?
Cashflow 43
Do the profits arrive as real cash?
Financial strength 33
Debt, balance sheet and risk of trouble
Investment 84
Does it invest with discipline instead of growing at any price?
Low Volatility 50
How calm the share price moves, does not count
Price momentum 45
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 53
Distance to the 52-week high, does not count
New shares 40
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 51/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+21.8%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+12.4%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+30.4%
Start year 2020 (pandemic)
Revenue growth 6 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+62.0%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−18.1% (2020) → 0.3% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

Growth Forecast

A lot of optimism in the price
The price assumes more growth than the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+62.7%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+9.0%
Yearly sales growth analysts expect, extended to five years.
After inflation (Canada: IMF forecast 2.1% a year to 2030, 2.6% from 2016 to 2025) that is about +59.3% a year for the price and +6.7% for the forecasts.
Forecast 2026 (sales)+20.8%
Forecast 2027 (sales)+7.2%
Projected 2028 (sales)+6.6%
Projected 2029 (sales)+5.9%
Projected 2030 (sales)+5.3%

Watch DB, get fair value alerts →

Earlier news

News mood ⓘNews mood, the average tone of recent news (7 articles), rated against how stocks are usually covered. 🚀 Hype = unusually upbeat · 🙂 Positive = above average · 😐 Neutral = typical · 🙁 Negative = below average · 😨 Very negative = unusually downbeat. It reflects the tone of coverage, not our valuation. Neutral
Recent news coverage is roughly neutral, about typical for how stocks are covered.

Compare Decibel Cannabis Company Inc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 554 stocks

Beats the industry median on 7/11 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 41 · Bottom 25%
Fair Value upside +50.5% · Top 25%
Profitability
Return on assets −2.1% · Bottom 25%
Net margin (12 months) −0.5% · Bottom 25%
Operating margin (12 months) 16.0% · Above median
Growth and dividend
Revenue growth (quarter YoY) 19.3% · Top 25%
Balance sheet
Debt / equity 0.42× · Highest 25%

Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper

P/B 1.23× · Cheaper than median
P/S (12 months) 0.61× · Cheapest 25%
Price / free cash flow 14.1× · Cheaper than median
EV/EBITDA 9.0× · Cheaper than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)100 · sector 16
FUTURE (revenue growth)97 · sector 25
PAST (return on equity)0 · sector 29
HEALTH (low debt)79 · sector 96
DIVIDEND (yield)0 · sector 33

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Zoetis Inc ZTS $89.20 $110.26 +24% vs DB
Sun Pharmaceutical Industries Limited SUNPHARMA ₹1,829 ₹1,947 +6% vs DB
Jiangsu Hengrui Pharmaceuticals Co 600276 ¥50.19 ¥53.31 +6% vs DB
Haleon plc HLN $9.23 $8.59 −7% vs DB
Merck KGaA MRK €150.35 €109.18 −27% vs DB
Galderma Group GALD CHF 195.15 CHF 109.26 −44% vs DB
Takeda Pharmaceutical Company TAK $21.06 $11.34 −46% vs DB
Teva Pharmaceutical Industries Limited TEVA $41.85 $20.75 −50% vs DB
Sandoz Group SDZ CHF 83.62 CHF 39.70 −53% vs DB
Divi's Laboratories Limited DIVISLAB ₹10,141 ₹1,567 −85% vs DB

Explore undervalued stocks

More undervalued Healthcare stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Decibel Cannabis Company Inc: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Decibel Cannabis Company Inc Fair Value". https://www.fairvalue-calculator.com/stock/DB

Frequently asked questions

Is Decibel Cannabis Company Inc (DB) overvalued or undervalued?
As of Nov 2, 2026, our model estimates a fair value of C$3.01 versus a price of C$2.00, about +51% upside (undervalued).
What is the fair value of DB?
Our model-based fair value for Decibel Cannabis Company Inc is C$3.01 (as of Nov 2, 2026), built from audited fundamentals. The current price: C$2.00.
What is the quality score of DB?
Decibel Cannabis Company Inc has a Quality Score of 41/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Decibel Cannabis Company Inc (DB)?
Our model-based price target is the fair value of C$3.01 (as of Nov 2, 2026) from 9 valuation models. Cautious scenario C$1.58, optimistic scenario C$5.91. It is a calculation from audited fundamentals, not an analyst target.
What is the Decibel Cannabis Company Inc stock forecast for 2026?
Our models put fair value at C$3.01, about +51% upside versus a price of C$2.00 (undervalued). Cautious scenario C$1.58, optimistic scenario C$5.91. The calculation is refreshed regularly with new filings.
What is the revenue of Decibel Cannabis Company Inc (DB)?
Decibel Cannabis Company Inc reported trailing-twelve-month revenue of about C$127M (latest available figure, as of Nov 2, 2026).
What growth is priced into Decibel Cannabis Company Inc (DB)?
For today's price to be fair in a discounted-cash-flow model, Decibel Cannabis Company Inc would have to grow free cash flow by +62.7 % per year for five years (discount rate 11.0 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +30.4 % per year. As of Nov 2, 2026.
What discount rate (WACC) does the fair value of DB use?
Our models discount Decibel Cannabis Company Inc at 11.0 %: a base by market capitalisation (micro), damped by beta 0.48, country premium for Canada. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Decibel Cannabis Company Inc that is +62.7 % per year a year over ten years, using the same discount rate (11.0 %) and the same formula as our fair value.
How much growth has Decibel Cannabis Company Inc (DB) delivered so far?
Over the past 5 years revenue at Decibel Cannabis Company Inc grew +30.4 % a year. The price currently implies +62.7 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Decibel Cannabis Company Inc (DB) growing?
The median revenue growth in the sector is +6.2 % a year. That is the yardstick for the growth priced into Decibel Cannabis Company Inc (+62.7 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Decibel Cannabis Company Inc (DB)?
The free-cash-flow yield on the price is 0.47 % in the last fiscal year (free cash flow was negative over the last twelve months): that much free cash flow Decibel Cannabis Company Inc produces per unit of market value. When it exceeds the discount rate of our models (11.0 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Decibel Cannabis Company Inc (DB)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Decibel Cannabis Company Inc it is C$3.01 per share (as of Nov 2, 2026), against a price of C$2.00. It is the blended result of 9 valuation models (cash flow, earnings, asset, dividend).
Is Decibel Cannabis Company Inc stock overvalued or undervalued in 2026?
As of Nov 2, 2026, DB trades below its calculated fair value: price C$2.00, fair value C$3.01, a gap of about +51% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of DB?
No. The price is what the market pays today (C$2.00); the fair value is what the company's own numbers justify (C$3.01). For Decibel Cannabis Company Inc the two are C$1.01 per share apart. That gap is exactly why we show both numbers side by side.
How much is Decibel Cannabis Company Inc worth?
The market values Decibel Cannabis Company Inc at about C$71.2M (market capitalisation, as of Nov 2, 2026). Per share that is C$2.00; our models calculate a fair value of C$3.01 per share.
What do the bullish and bearish scenarios say about DB?
Our models span a range for Decibel Cannabis Company Inc: cautious scenario C$1.58, base C$3.01, optimistic C$5.91 per share (as of Nov 2, 2026, price C$2.00). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Decibel Cannabis Company Inc (DB)?
Balance-sheet figures for Decibel Cannabis Company Inc (as of Nov 2, 2026): return on equity −1.0%, debt of 0.42 per unit of equity. They feed the Quality Score of 41/100, which measures business quality independently of the share price.
How far is DB from its 52-week high?
Decibel Cannabis Company Inc trades at C$2.00, about 8% below its 52-week high of C$2.18 and 48% above the low of C$1.35 (as of Nov 4, 2026). Distance from the high says nothing about value: that is what the fair value of C$3.01 is for.
Which stocks are comparable to Decibel Cannabis Company Inc?
From the same area (Healthcare) we also value Merck KGaA, Takeda Pharmaceutical Company, Galderma Group, Teva Pharmaceutical Industries Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Decibel Cannabis Company Inc stock attractive at the current price?
The data as of Nov 2, 2026: price C$2.00, calculated fair value C$3.01 (+51%), Quality Score 41/100, from 9 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of DB calculated?
We run Decibel Cannabis Company Inc through 9 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of C$3.01, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 15.6% above its aggregate fair value. Decibel Cannabis Company Inc currently trades 34% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Decibel Cannabis Company Inc (DB)?
The closing price on Nov 4, 2026 was C$2.00. Our model-based fair value is C$3.01, about +51% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Decibel Cannabis Company Inc right now?
The large discount to fair value meets weak quality (41/100). That raises the risk this is a value trap rather than a bargain. The model range is unusually wide (C$1.58 to C$5.91). The outcome hinges heavily on assumptions, so read the point estimate with caution.

Key figures of Decibel Cannabis Company Inc

How large is the market capitalisation of Decibel Cannabis Company Inc (DB)?
The market capitalisation of Decibel Cannabis Company Inc is C$71.2M (≈ $50.8M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Decibel Cannabis Company Inc (DB)?
The price-to-sales ratio of Decibel Cannabis Company Inc is 0.56 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Decibel Cannabis Company Inc (DB)?
Earnings per share at Decibel Cannabis Company Inc are C$−0.1500. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Decibel Cannabis Company Inc (DB)?
The net margin of Decibel Cannabis Company Inc is −2.6% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Decibel Cannabis Company Inc (DB)?
The return on equity (ROE) of Decibel Cannabis Company Inc is −1.0% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Decibel Cannabis Company Inc (DB)?
On an EBIT basis the return on assets of Decibel Cannabis Company Inc is 2.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Decibel Cannabis Company Inc (DB)?
The operating margin of Decibel Cannabis Company Inc is 16.0% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Decibel Cannabis Company Inc (DB)?
Revenue at Decibel Cannabis Company Inc is growing +19.3% versus a year earlier (3y avg +12.4%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Decibel Cannabis Company Inc (DB)?
Earnings per share at Decibel Cannabis Company Inc are growing +154% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Decibel Cannabis Company Inc (DB) carry?
The net debt of Decibel Cannabis Company Inc is C$27.8M (fiscal year 2025, ≈ 5.1 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Decibel Cannabis Company Inc in the live analysis

One click puts Decibel Cannabis Company Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.